497 related articles for article (PubMed ID: 12549927)
1. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
2. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
Zhitkovich A; Song Y; Quievryn G; Voitkun V
Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
[TBL] [Abstract][Full Text] [Related]
3. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
Quievryn G; Messer J; Zhitkovich A
Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
[TBL] [Abstract][Full Text] [Related]
4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
5. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
Voitkun V; Zhitkovich A; Costa M
Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499
[TBL] [Abstract][Full Text] [Related]
6. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
Guttmann D; Poage G; Johnston T; Zhitkovich A
Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
Quievryn G; Messer J; Zhitkovich A
Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
[TBL] [Abstract][Full Text] [Related]
8. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair.
Reynolds M; Stoddard L; Bespalov I; Zhitkovich A
Nucleic Acids Res; 2007; 35(2):465-76. PubMed ID: 17169990
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum induced by chromium(III) in shuttle vectors replicated in human cells: relationship to Cr(III)-DNA interactions.
Tsou TC; Lin RJ; Yang JL
Chem Res Toxicol; 1997 Sep; 10(9):962-70. PubMed ID: 9305577
[TBL] [Abstract][Full Text] [Related]
10. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
Tsou TC; Lai HJ; Yang JL
Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
[TBL] [Abstract][Full Text] [Related]
11. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
12. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity.
Pattison DI; Davies MJ; Levina A; Dixon NE; Lay PA
Chem Res Toxicol; 2001 May; 14(5):500-10. PubMed ID: 11368547
[TBL] [Abstract][Full Text] [Related]
13. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
[TBL] [Abstract][Full Text] [Related]
14. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
Liu S; Dixon K
Environ Mol Mutagen; 1996; 28(2):71-9. PubMed ID: 8844987
[TBL] [Abstract][Full Text] [Related]
15. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
Zhitkovich A; Shrager S; Messer J
Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
[TBL] [Abstract][Full Text] [Related]
16. Characterization of nonmutagenic Cr(III)-DNA interactions.
Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
Quievryn G; Goulart M; Messer J; Zhitkovich A
Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
[TBL] [Abstract][Full Text] [Related]
18. Chromium genotoxicity: A double-edged sword.
Nickens KP; Patierno SR; Ceryak S
Chem Biol Interact; 2010 Nov; 188(2):276-88. PubMed ID: 20430016
[TBL] [Abstract][Full Text] [Related]
19. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).
Krawic C; Zhitkovich A
Adv Pharmacol; 2023; 96():25-46. PubMed ID: 36858775
[TBL] [Abstract][Full Text] [Related]
20. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms.
O'Brien TJ; Ceryak S; Patierno SR
Mutat Res; 2003 Dec; 533(1-2):3-36. PubMed ID: 14643411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
